Autolus Therapeutics (AUTL) Misses Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: AUTL) | Delayed: 1.60 -0.03 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.63 | 52 Week High | $ | |||
| Open | $1.63 | 52 Week Low | $ | |||
| Day High | $1.65 | P/E | N/A | |||
| Day Low | $1.57 | EPS | $ | |||
| Volume | 1,896,667 | |||||
